GC
INVA icon

Grimes & Company’s Innoviva INVA Stock Holding History

Grimes & Company’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Sell
9,722
-147
-1% -$3.37K ﹤0.01% 421
2026
Q1 		$230K Sell
9,869
-1,674
-15% -$36.1K 0.01% 398
2025
Q4 		$231K Buy
11,543
+219
+2% +$4.28K 0.01% 420
2025
Q3 		$207K Hold
11,324
– – 0.01% 436
2025
Q2 		$227K Hold
11,324
– – 0.01% 386
2025
Q1 		$205K Sell
11,324
-573
-5% -$10.3K 0.01% 353
2024
Q4 		$206K Hold
11,897
– – 0.01% 367
2024
Q3 		$230K Hold
11,897
– – 0.01% 328
2024
Q2 		$195K Buy
11,897
+83
+0.7% +$1.29K 0.01% 332
2024
Q1 		$180K Sell
11,814
-285
-2% -$4.48K 0.01% 324
2023
Q4 		$194K Sell
12,099
-260
-2% -$3.63K 0.01% 306
2023
Q3 		$161K Buy
12,359
+147
+1% +$1.91K 0.01% 284
2023
Q2 		$155K Hold
12,212
– – 0.01% 291
2023
Q1 		$137K Buy
12,212
+1,078
+10% +$13.1K 0.01% 281
2022
Q4 		$148K Sell
11,134
-101
-0.9% -$1.33K 0.01% 273
2022
Q3 		$130K Buy
11,235
+309
+3% +$4.24K 0.01% 262
2022
Q2 		$161K Sell
10,926
-1,999
-15% -$32.7K 0.01% 261
2022
Q1 		$250K Buy
12,925
+1,205
+10% +$21.5K 0.01% 258
2021
Q4 		$202K Sell
11,720
-271
-2% -$4.62K 0.01% 287
2021
Q3 		$200K Buy
11,991
+1,250
+12% +$18.7K 0.01% 288
2021
Q2 		$144K Buy
+10,741
New +$134K 0.01% 291
2020
Q2 		– Sell
-12,800
Closed -$151K – 253
2020
Q1 		$151K Sell
12,800
-400
-3% -$5.29K 0.01% 213
2019
Q4 		$187K Buy
+13,200
New +$162K 0.01% 253

Other funds holding INVA

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Grimes & Company's INVA Position: Q2 2026 in Review

Grimes & Company reduced its Innoviva (INVA) stake by 1.5% in Q2 2026, selling an estimated $3.37K and leaving 9,722 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #421.

Grimes & Company first reported a position in INVA in Q4 2019 and has held it in 23 quarters since. The position peaked at $250K in Q1 2022. 70 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Grimes & Company held 9,722 shares of Innoviva worth $221K as of Q2 2026.
  • Grimes & Company sold 147 Innoviva shares in Q2 2026, an estimated $3.37K.
  • Innoviva made up ﹤0.01% of Grimes & Company's portfolio in Q2 2026, its #421 holding.
  • Grimes & Company first reported a position in Innoviva in Q4 2019 and has held it in 23 quarters since.
  • Grimes & Company's Innoviva position peaked at $250K in Q1 2022.
  • 70 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.